Last reviewed · How we verify
Multiprofen-CC™ plus standard treatment — Competitive Intelligence Brief
phase 3
Small molecule
Live · refreshed every 30 min
Target snapshot
Multiprofen-CC™ plus standard treatment (Multiprofen-CC™ plus standard treatment) — McMaster University. Multiprofen-CC™ is an anti-inflammatory agent combined with standard treatment to reduce inflammation and improve clinical outcomes.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Multiprofen-CC™ plus standard treatment TARGET | Multiprofen-CC™ plus standard treatment | McMaster University | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Multiprofen-CC™ plus standard treatment CI watch — RSS
- Multiprofen-CC™ plus standard treatment CI watch — Atom
- Multiprofen-CC™ plus standard treatment CI watch — JSON
- Multiprofen-CC™ plus standard treatment alone — RSS
Cite this brief
Drug Landscape (2026). Multiprofen-CC™ plus standard treatment — Competitive Intelligence Brief. https://druglandscape.com/ci/multiprofen-cc-plus-standard-treatment. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab